ACQUISITIONS (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2019 |
Sep. 30, 2018 |
Mar. 31, 2018 |
|
| Escrow [Member] | |||
| Common stock, shares issued | 192,758 | ||
| Common stock shares issued, value | $ 640 | ||
| Asset purchase agreement [Member] | |||
| Cash paid as consideration | $ 4,120 | ||
| Common stock, shares issued | 633,348 | ||
| Common stock shares issued, value | $ 2,100 | ||
| Cancelled shares | 101,083 | ||
| Cancelled shares, amount | $ 350 | ||
| MediFarm So Cal Inc [Member] | |||
| Fair value of the management services agreement adjustment | $ 6,300 | ||
| Decrease in amortization expense | $ 430 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Carrying amount of assets sold under agreements to repurchase when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceeds 10 percent of total assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|